As a psychologist who has served as a therapist and site co-principal investigator in clinical trials of MDMA and psilocybin, I'm often asked what conditions psychedelic therapy can treat and how it ...
Psychedelics work on the brain by increasing the functional connection between the thinking and sensory regions, temporarily blurring the line between perception and thought, an international ...
Sept. 11, 2025 -- Psychedelics like ketamine, psilocybin, and MDMA are emerging as promising treatments for mood disorders that don’t respond to standard care. What has research shown using these ...
Hosted on MSN
Psychedelics and non-hallucinogenic analogs work through the same receptor—up to a point
Understanding exactly how psychedelics promote new connections in the brain is critical to developing targeted, non-hallucinogenic therapeutics that can treat neurodegenerative and neuropsychiatric ...
Psychedelics can quiet the brain’s visual input system, pushing it to replace missing details with vivid fragments from memory. Scientists found that slow, rhythmic brain waves help shift perception ...
The Lancet published an Editorial on reviving research into psychedelics for mental health conditions, observing that “the ...
FILE PHOTO: U.S. President Donald Trump signs an executive order encouraging more research into ibogaine, next to U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., Joe Rogan, and ...
Reardon is a senior at the Wharton School at the University of Pennsylvania, head of marketing at Truxtun, a veteran-focused psychedelic retreat company, and a writer at Tripwire, a news blog covering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results